The S100A7 gene helps skin cells support the skin barrier and send signals that help defend against germs. If it is not working normally, your skin may be less balanced in how it protects itself and manages inflammation. In medicine, this gene is important because changes in its activity have been linked to psoriasis and some other inflammatory skin conditions. Researchers also study it in certain cancers, especially breast cancer, as a marker of how cells are behaving.
What is a gene?
Genes are pieces of DNA that carry instructions your cells use to make molecules or manage processes in the body. Some genes hold the directions for producing proteins, the parts of cells that do the work. Others mainly control when specific processes happen, where they occur, and how strongly they are carried out. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. To explore this subject further, you can find more in LearnHub.
Overview
S100A7Gene function
What if the gene works
The S100A7 gene helps skin cells support the skin barrier and respond to germs. Its protein is especially active in the outer skin, where it supports local immune signaling.
Risk
What if the gene does not work
Changes in the S100A7 gene can range from milder to more severe variants. These changes may alter how skin cells signal stress and make the psoriasin protein, which helps support the skin barrier and local germ-fighting responses.
Treatment
What does that mean for your treatment
No S100A7-specific treatment or management approach is currently established in clinical guidelines. The S100A7 gene is being studied mainly as a biomarker and possible drug target in psoriasis and some cancers, but this has not yet changed routine treatment choices.
Gene function
What if the gene works
In healthy skin, the S100A7 gene helps surface cells respond to daily contact with germs and irritation. It is most active in the outer layers of the skin, where barrier support and local immune signals are especially important. Understanding how the S100A7 gene works in the skin helps explain how your body protects itself at the surface.
This gene helps skin cells make a protein that can limit the growth of some bacteria on the skin surface. That supports your skin’s early, local defense during everyday exposure.
The protein from the S100A7 gene is active as skin cells mature and form the outer covering of the body. This helps the skin surface stay organized and ready to act as a protective barrier.
This gene makes a protein that binds calcium, which is a common signal used by cells. That helps skin cells adjust their activity in a controlled way during normal turnover and routine immune communication.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and are part of normal human diversity, including variations in appearance, metabolism, or how the body responds to environmental influences. Many have no noticeable effect and simply represent natural genetic variation. Sometimes, though, a variant can more substantially change how a gene works and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the S100A7 gene can change how much S100A7 protein a cell makes or alter the protein’s shape, stability, and binding to calcium, zinc, or partner molecules. This is one of the main ways S100A7 gene variants may affect protein activity inside skin and immune cells. Milder variants may slightly shift expression or signaling, while more severe variants can more clearly reduce folding, secretion, or normal molecular interactions.
How variants are linked to conditions
The S100A7 gene does not yet have a broadly confirmed link to a specific health condition, although research on how S100A7 gene variants are linked to conditions is still evolving. If you have a confirmed finding in this gene, your doctor or genetic counselor can explain what it may mean in the context of your own health.
A variant is not necessarily a diagnosis
Genetic variants are a common and expected part of human biology in the general population. Most do not directly affect health and instead reflect natural variation among people. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences play a role. In some situations, though, one well-studied variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the S100A7 gene itself. If S100A7 is being discussed as part of psoriasis, skin inflammation, or cancer-related testing, personal risk is usually shaped by the wider condition, family history, and other health factors rather than this gene alone.
Inheritance of S100A7 variants
There is not yet a broadly confirmed disease inheritance pattern for the S100A7 gene, so S100A7 gene inheritance is not described as a clear autosomal dominant, autosomal recessive, or X linked condition at this time. The S100A7 gene is located on chromosome 1, which is an autosome, so you inherit one copy from each parent. That means any variant in this gene can be passed through either side of the family, although its health effects are still being worked out.
What does my S100A7 result mean for my family?
There is not yet a broadly confirmed inherited pattern tied to a specific condition for S100A7. If you have an S100A7 result and want to understand what it could mean for relatives, a doctor or genetic counselor can explain it in the context of your personal and family health history.
Genetic information
Genetic testing
How you find out about variants
Variants in the S100A7 gene are found with DNA testing from a blood or saliva sample, using sequencing to read the gene and look for changes. Genetic testing for S100A7 variants may be part of a broader multi-gene panel, and results show whether a variant was detected and how clearly it is linked to health effects.
When should I consider getting a genetic test?
There is not yet a broadly established, S100A7-specific reason for genetic testing in routine care. Testing decisions are usually based on your personal health history, family history, and whether a doctor or genetic counselor thinks a broader test would be more useful.
A genetic result is only one part of your health story
A genetic result can provide valuable insight, but how much it reveals depends on the condition and the type of variant involved. Over time, how the body functions is also shaped by many factors, including lifestyle, environment, age, and medical history. In some conditions, especially those affected by many genes, genetic information provides context rather than certainty and is most useful when viewed alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same drug may work well for one person, have little effect in another, or cause more side effects in someone else. Differences in how the body absorbs, breaks down, transports, or responds to a medicine are common and can influence both how well a treatment works and how sensitive a person is to it.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way people respond to medications. It studies links between genes and drugs to better explain why the same treatment can work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body processes it. This information can support more informed and more individualized treatment decisions. More on this topic is available in the LearnHub.
Drugs influenced by the S100A7 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medicine choices, so general health questions and any concerns about a new medicine, side effects, or treatment changes are best discussed with your doctor or pharmacist. Seek medical advice promptly for severe reactions such as trouble breathing, swelling, a widespread rash, fainting, or chest pain.
History
S100A7 first drew attention in the 1990s when researchers found it at high levels in skin affected by psoriasis, which led to the name psoriasin. First described in the scientific literature as part of early genetics, it became a useful marker in studies of skin inflammation. From these first observations, research expanded steadily into other tissues, including the breast, where S100A7 was later linked to certain breast cancer patterns. Scientific classifications changed as researchers learned more about the gene. Over time, S100A7 came to be recognized as part of the broader S100 family of genes, a group studied for their role in inflammation and cell signaling. Its history is closely tied to progress in dermatology and cancer research.